MedPath

山东鑫齐药业有限公司

Ownership
-
Established
2004-02-27
Employees
-
Market Cap
-
Website
www.xinqiyaoye.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

28

NMPA:28

Drug Approvals

Raceanisodamine

Product Name
消旋山莨菪碱
Approval Number
国药准字H20084529
Approval Date
Apr 26, 2024
NMPA

Diammonium Glycyrrhizinate

Product Name
甘草酸二铵
Approval Number
国药准字H20074034
Approval Date
Apr 9, 2024
NMPA

Venlafaxine Hydrochloride

Product Name
盐酸文拉法辛
Approval Number
国药准字H20083066
Approval Date
Apr 9, 2024
NMPA

健胃消食片

Approval Number
国药准字Z20093343
Approval Date
Nov 28, 2023
NMPA

华蟾素胶囊

Approval Number
国药准字Z20090944
Approval Date
Nov 20, 2023
NMPA

小儿麻甘颗粒

Approval Number
国药准字Z20093208
Approval Date
Nov 20, 2023
NMPA

根痛平胶囊

Approval Number
国药准字Z20090175
Approval Date
Nov 20, 2023
NMPA

Amlodipine Besilate Tablets

Product Name
苯磺酸氨氯地平片
Approval Number
国药准字H20083834
Approval Date
May 28, 2023
NMPA

Simvastatin Tablets

Product Name
辛伐他汀片
Approval Number
国药准字H20084420
Approval Date
May 28, 2023
NMPA

小儿腹泻散

Approval Number
国药准字Z20083055
Approval Date
May 16, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.